Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Platelet Rich Plasma in Posterior Lumbar Interbody Fusion
NCT03261843Phase 4Unknown
- Sponsor
- Assiut University
- Start
- Nov 2017
- Primary completion
- Jan 2019
- Modality
- Adoptive Cell Transfer
01
Overview
Phase 4, randomised trial of autologous platelet-rich plasma in spondylolisthesis and degenerative disc disease (DDD) (2 arms), sponsored by Assiut University. Primary endpoint: Bridging Trabecular Bone Scale at 6 months. Status: unknown.
02
Drugs
autologous platelet-rich plasma
03
Conditions
spondylolisthesisdegenerative disc disease (DDD)
Beyond the preview
Go deeper on NCT03261843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03261843.